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Abstract
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In previous studies, we demonstrated that elongation of side chains of several sensitizers endowed
them with higher affinity for artificial and natural membranes and caused their deeper localization
in membranes. In the present study, we employed eight hematoporphyrin and protoporphyrin
analogs and four groups containing three chlorin analogs each, all synthesized with variable
numbers of methylenes in their alkyl carboxylic chains. We show that these tetrapyrroles’ affinity
for bovine serum albumin (BSA) and their localization in the binding site are also modulated by
chain lengths. The binding constants of the hematoporphyrins and protoporphyrins to BSA
increased as the number of methylenes was increased. The binding of the chlorins depended on the
substitution at the meso position opposite to the chains. The quenching of the sensitizers’
florescence by external iodide ions decreased as the side chains became longer, indicating to
deeper insertion of the molecules into the BSA binding pocket. To corroborate this conclusion, we
studied the efficiency of photodamage caused to tryptophan in BSA upon illumination of the
bound sensitizers. The efficiency was found to depend on the side-chain lengths of the
photosensitizer. We conclude that the protein site that hosts these sensitizers accommodates
different analogs at positions that differ slightly from each other. These differences are manifested
in the ease of access of iodide from the external aqueous phase, and in the proximity of the
photosensitizers to the tryptophan. In the course of this study, we developed the kinetic equations
that have to be employed when the sensitizer itself is being destroyed.
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Introduction
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The interaction of photosensitizer molecules with proteins, artificial and natural membranes
and cells has been a rich and active field of research in the recent 25 years, because of the
advent of biological photosensitization and photo-dynamic therapy (PDT). PDT is a twostage treatment of malignant tissues, which uses a photosensitizing drug and preferentially
red, nonthermal, light. The photosensitizer absorbs light and generates cytotoxic singlet
oxygen and other reactive oxygen species, leading to cellular damage (Henderson and
Dougherty 1992; Pandey 2000; Smith and Hahn 2002; Verma et al. 2007). The strength of
the PDT effect depends on the light dose that is absorbed, on the sensitizer concentration, on
oxygen availability (Kreimer-Birnbaum 1989; Jori 1992) as well as on the photophysical
parameters of the sensitizing compounds (Boyle and Dolphin 1996). Most of current
research on PDT is focused on the treatment of cancer; however, other PDT applications
should not be omitted, including autoimmune diseases, atherosclerosis and killing of
microorganisms and viruses (Dougherty 2002; Jori and Brown 2004; Wainwright 2004).
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Tetrapyrrole-based molecules, which are used as sensitizers, have a pronounced tendency to
aggregate in aqueous solutions, and thus are mostly transported in blood and delivered to
tumor cells either as aggregates or as proteinbound monomers. Dissociation or partial
disaggregation of large aggregates occurs upon binding to serum proteins and within tumor
cells. The type of protein-carrier conjugate governs the delivery of sensitizer to the tumor
(Jori and Reddi 1993). Serum albumin, the most abundant protein in blood plasma, serves as
a carrier for amphiphilic and hydrophilic photosensitizers (Kongshaug 1992); hydrophobic
molecules bind preferentially to low-density lipoproteins and transferrin and are taken up by
receptormediated endocytosis (Kongshaug et al. 1989). Carriers can be useful, especially
when hydrophobic photosensitizers are employed (Dougherty et al. 1998; Rosenkranz et al.
2000). Conjugates of hematoporphyrin IX (HP3) with serum albumin and transferrin were
prepared for application in biological photosensitization (Hamblin and Newman 1994).
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In this work, we studied the effect of molecular structure of two groups of porphyrins and
four groups of chlorins on their mode of binding to bovine serum albumin (BSA). We
employed two series of hematoporphyrins and protoporphyrins, which were modified so that
the alkyl carboxylate side chains of each molecule contained two, five or seven carbon
atoms in each chain, in addition to natural hematoporphyrin IX (HP) and protoporphyrin IX
(PP), which contain three carbon atoms in each chain. We also used four newly synthesized
series of chlorins, which differ from each other by a major side group at the meso position
and within each group they differ by the length of the alkyl carboxylate side chains,
containing two, three or four carbon atoms. In previous studies (Lavi et al. 2001; Bronshtein
et al. 2004; Bronshtein et al. 2005; Minnes et al. 2008; Ben Dror et al. 2009), we
demonstrated that elongation of the side chains increased the affinity of the modified
porphyrins for artificial membranes. It also caused a displacement of the bulk of the
tetrapyrrole to a deeper location inside the lipid bilayer membrane. This, in turn, resulted in
an increase in the observed efficiency of photosensitized degradation of membrane-residing
singlet oxygen targets, because singlet oxygen had an opportunity to diffuse a longer
distance in the membrane before escaping into the aqueous phase. It may also be the reason
for an increased in situ photosensitization of cells that absorbed these sensitizers and even an
increase in the in vivo PDT effect in mice (Bronshtein et al. 2006).
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We report in this study that when the sensitizers were bound to BSA, iodide caused lesser
quenching of their fluorescence as the sensitizer side chains increased in length, indicating
that they were better shielded from an external iodide ion. We also show that singlet oxygen,
which is generated by illumination of the sensitizers, causes differential damage to
tryptophan in BSA. The present study thus demonstrates that modifications of side chains of
the studied chlorins and porphyrins are manifested in the way these molecules are localized
within the active site of albumin. The lipid:water interface of membranes is defined and it is
thus not surprising that it can act as an anchoring point for amphiphilic photosensitizers. In
the current manuscript we show, however, that delicate changes in the localization of the
same chlorins, as well as porphyrins, can arise even in a case when these molecules are
bound in the protein, with its less defined phase boundaries. These differences result in
changes in the spectroscopic and photophysical properties of the bound sensitizers.

Materials and methods
Chemicals and sample preparation
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Protoporphyrin IX and hematoporphyrin IX were obtained from Sigma (St. Louis, MO). The
other protoporphyrin and hematoporphyrin derivatives, with alkyl carboxylate groups
containing two, five or seven carbon atoms in each chain (Fig. 1), were custom synthesized
for this project. These syntheses were accomplished from monopyrroles using the a,cbiladiene route (Holmes 1997). 2-Formyl-3,5-dimethylpyrroles bearing 4-ester side chains
with different numbers of chain methylenes (n = 1,4,6) were individually reacted with the
same dihydrodipyrrin to provide the corresponding a,c-biladiene salts; these were then
cyclized using the copper(II) oxidation procedure (Smith 2000). All synthetic porphyrins
were fully characterized using spectrophotometry, proton NMR spectroscopy and elemental
analysis and/or high-resolution mass spectrometry. None showed evidence of any
impurities. The proto- and hematoporphyrins are named HP2, PP2, HP3, PP3, HP5, PP5,
HP7 and PP7, where the digit corresponds to the total number of carbon atoms in each of the
two side chains.
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The chlorins were synthesized using a new synthetic approach for chlorins (2 + 2 Method)
(O’Neal et al.2006). This method is based on a variant of the MacDonald porphyrin
synthesis (Arsenault et al. 1960) and involves condensation of bis-formyldihydrodipyrrins
with symmetrical dihydrodipyrrins (Jacobi et al. 2001). By this approach the chlorin
chromophore is obtained directly in the proper oxidation state and with no need for
subsequent isomerization.
Stock solutions of the porphyrins (0.1 mM) and the chlorins (1 mM) were prepared in
DMSO. Phosphatebuffered saline (PBS), at pH = 7.4, was used to prepare stock solutions of
BSA (0.01 g/ml = 0.15 mM), KI (8 M) and Na2S2O3 (0.2 M). KCl, up to a concentration of
0.15 M, in the case of the porphyrins and up to 0.24 M in the chlorins, was added to these
buffer solutions in order to keep the total ionic strength constant.
Spectroscopic measurements
Absorption spectra were recorded on a Perkin-Elmer (Norwalk, CT) Lambda-9 UV–visible–
near-IR, computer-controlled spectrophotometer and on a Shimadzu (Kyoto, Japan)
UV-2501PC UV–vis spectrophotometer. Fluorescence excitation and emission spectra and
fluorescence time-drive measurements were performed on a Perkin-Elmer LS-50B digital
fluorimeter. For fluorescence measurements, all samples had optical density <0.05 at the
wavelength of excitation, to maintain linear dependence of fluorescence intensity on
concentration.
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Measurement of binding constants to BSA
The sensitizers were added from their stock solutions in DMSO to PBS buffer, keeping the
final volume of DMSO at <1% of the total volume of buffer. The final concentration of
porphyrins in the samples was 0.1 μM. The binding constant, Kb, of each sensitizer to BSA
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was measured spectroscopically. Kb is defined as:
, where [Pi] is the
concentration of the protein-bound, or aqueously dissolved porphyrin, and [M] is the
concentration of the binding protein. Kb is thus given in units of [protein concentration]−1.
After each addition of an aliquot of BSA from its stock, emission spectra were recorded
following a very short incubation time of <1 min, at which equilibrium of binding was
reached. For binding studies of HP derivatives we used λex = 400 nm and λem = 623 nm.
For binding of PP derivatives λex = 402 nm and λem = 629 nm. For the chlorins binding,
λex = 400 nm and λem = 639–653 nm, according to each chlorin’s emissions peak.
Fluorescence quenching by iodide ions
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A set of samples was prepared for each porphyrin or chlorin derivative, containing the
sensitizer (at 10−7 M), 10−5 M of Na2S2O3 to prevent oxidation of I− to colored I2, and
increasing concentrations of KI (0–0.15 M). All samples contained KCl, which was added to
the KI to a total electrolyte concentration of 0.15 M, to maintain a constant ionic strength.
The wavelengths at which the iodide quenching experiments were done were as outlined in
the previous section. For these experiments, we used 0.015 g BSA/ml, a concentrations that
is high enough to ensure that all the porphyrins were almost fully bound (>99%) to BSA. In
the chlorins’ measurements the sensitizer concentration was 1.5 × 10−7 M, KI concentrations
increase to 0.24 M and the BSA concentration was 0.01 g/ml, which was high enough for all
the chlorins to be fully bound (>99%) to BSA.
Damage to tryptophan in BSA by photosensitization
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The tryptophan in BSA acts as a chemical trap of singlet oxygen, which is being generated
upon illumination of the bound photosensitizers. Tryptophan’s degradation in this process
was monitored by following its fluorescence intensity. BSA concentration was 0.02 g/ml;
the chlorin concentration was 3 × 10−6 M (this concentration is required to obtain a reliably
measured absorbance). The intensity of tryptophan fluorescence was measured (λex = 295
nm, λem = 340 nm) in a time-drive mode, while the sensitizer was being illuminated in situ
in the fluorimeter by an Ar+ laser (Stabilite 2017, Spectra-Physics, Mountain View, CA)
beam at 501.7 nm. The illuminating laser beam passed along the cuvette’s long axis,
perpendicular to the fluorimeter excitation and emission directions. The laser power (around
30 mW) was measured at the sample surface with a power meter (model PD2-A, Ophir,
Jerusalem, Israel), before and after the measurements, to ensure that the power remained
constant during the experiment. The disappearance of tryptophan fluorescence followed
decay kinetics, which will be detailed later.
Measurement of singlet oxygen quantum yields in methanol
The absolute quantum yields of production of singlet oxygen were measured by employing
the singlet oxygen chemical trap 9,10 dimethylanthracene (DMA). The fluorescence of
DMA disappears when it is oxidized by singlet oxygen and so the kinetics of the decrease of
its fluorescence is measured for each studied sensitizer, in comparison to that generated by
Rose Bengal, a standard sensitizer whose singlet oxygen yield is known. This method was
described by us before (Sholto et al. 2008).
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Results and discussion
Binding of derivatives of hematoporphyrin, protoporphyrin and chlorin to BSA
The uptake of various sensitizers by albumin, and other serum proteins, has been studied
extensively in the literature (Reddi et al. 1987; Kongshaug 1992; Korbelik 1993; Gantchev
et al. 1999). In this study, we were interested in evaluating the effect of structural
modifications of the sensitizers on the affinities of their binding to BSA and on the location
of the bound sensitizers. The following formula was used to evaluate the binding constant of
the sensitizers to BSA, Kb (Ehrenberg 1992):

$watermark-text

(1)

Finit is the fluorescence intensity of the sensitizers, measured in the absence of protein; F is
the intensity measured in the presence of protein at concentration [P]; Fcomp is the
fluorescence intensity, which is achieved asymptotically upon complete binding at infinite
protein concentration. We measured the fluorescence intensity of the binding chromophores
and the results of F versus [P] were fitted to the above function, to yield Kb and Fcomp.
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We did not observe aggregation of the studied sensitizers at the low concentrations (below
0.1 μM) that were used, as evident from the linear dependence of absorbance on
concentration. Upon binding to proteins or to lipid membranes a remarkable increase in
fluorescence intensities is observed (Aveline et al. 1995). The enhanced fluorescence
intensity upon entering the lipid or protein domains is accompanied by the common red shift
in the emission spectrum. With the HP derivatives the fluorescence peak shifts from 618 to
623 nm, in the case of PP derivatives the peak shifts from 620 to 629 nm, and with the
chlorin derivatives the peak red-shifts by 3–10 nm, depending to the substituent at the meso
position. The spectroscopic changes arise from different interactions of the chromophoric
molecules with water and with the lipid or the protein cavity, as the polarity of the latter
environments is lower than that of water. The binding constants of the studied sensitizers to
BSA are presented in Table 1.
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The binding constants of the four hematoporphyrins and four protoporphyrins to BSA
exhibit a general increasing trend as the number of carbon atoms in the carboxylate chains
increases. There is also a general trend that protoporphyrins bind better than
hematoporphyrins with the same side chains. The trends are expected and are explainable on
the basis of an increase in the hydrophobicity upon elongation of the alkyl carboxylate
chains of the porphyrins, as was observed in many earlier cases (Kępczyński et al. 2002).
The chlorins do not show a common behavior of binding to BSA. The groups with methyl
and phenyl substituents (classes BX and CX, respectively) exhibit an increased binding to
BSA as the length of the side chains increases. In contrast, group DX, with pentyl
substitution exhibits a decreased BSA affinity as the chains lengthen. There is thus an
inverse correlation between the lipophilicity of chlorins in this group and their affinity for
BSA. Despite the accumulation of large amount of data regarding drug binding to plasma
proteins, the prediction of this binding continues to be problematic (Kratochwil et al. 2002).
In several cases, such as here, increased apolarity of a tetrapyrrole sensitizer is concomitant
with lowered BSA binding while in many other instances the trend is reversed (Borissevitch
et al. 1996; Bose and Dube 2006; Mishra et al. 2006). Group AX, without substitution at the
meso position has a non-descript behavior.
To evaluate the numbers of albumin binding sites for the studied porphyrins and chlorins we
resorted to another methodology. When the binding of a ligand to a protein site elicits static
quenching to a fluorophore in the protein, such as tryptophan, the binding constant and the
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number of binding sites can be calculated, using the following equation (Tian et al. 2003;
Min et al. 2004):
(2)

where F0 and F are the fluorescence intensities of the tryptophan without and with the bound
quencher (chlorin or porphyrin in our study), respectively, [Q] is the concentration of this
quencher, and Kb and n are the binding constant and number of binding sites, respectively. n
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can thus be obtained from the slope of a plot of
versus log[Q]. Kb can, in
principle, also be calculated, from the intersection of the fitted line with the y-axis. We
found, however, that since the values of [Q], namely the concentration of sensitizers, were in
the range of 10−6–7 × 10−6 M, the intercept was extremely sensitive to the calculated slope
of the line. A small (<10%) change in this slope would have led to >70% variation in Kb.
We used therefore Eq. 2 to calculate n only, and we preferred using Eq. 1 to calculate Kb.
The values of n are shows in Table 1. As can be seen, in all the cases the result was very
close to 1, indicating to one specific binding site of BSA for these tetrapyrrole sensitizers. A
previous study also showed that BSA had one binding site for HP (Feng et al. 1996).
Fluorescence quenching of sensitizers bound to BSA
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The quenching efficiency of fluorescing molecules by iodide ions was shown to be a tool in
assessing the relative vertical depth of membrane-bound fluorophores, including porphyrins
(Chalpin and Kleinfeld 1983; Cranney et al. 1983; Moro et al. 1993). We have demonstrated
in previous studies, by employing fluorescence quenching methodologies, that the
tetrapyrrole core of hematoporphyrins, protoporphyrins or dithiaporphyrins was located at
larger depths in the membrane as the alkyl carboxylate side chain was made longer,
containing from 2 up to 7 carbon atoms in a chain of the porphyrins and from 2 to 10 in the
dithiaporphyrins (Lavi et al. 2001; Bronshtein et al. 2004; Minnes et al. 2008). We wanted to
explore whether the exact location of sensitizers in albumin’s binding site is also affected by
similar modifications. We therefore employed here, too, fluorescence quenching by external
iodide ions as an indicator for the sensitizer accessibility from the external aqueous phase.
Fluorescence quenching is associated with a quenching constant, Kq, which is obtained from
the Stern–Volmer Eq. 3:
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(3)

F0 and F are fluorescence intensities in the absence and in the presence of the quencher,
respectively, whose concentration is [Q]. In order to obtain Kq for each studied derivative,
data of F0/F were plotted versus [Q] and fitted to Eq. 3 by a linear regression routine.
Figure 2 shows, as an example, the quenching of chlorine AD by iodide. In all cases we
obtained linear Stern–Volmer quenching plots, with y-axis intercepts very close to 1. We
employed high enough BSA concentration, 0.01 g/ml, to ensure that practically all the
sensitizers were bound to BSA and there were no different populations of fluorophores, in
terms of their quenching ability. Iodide ions are known as dynamic, collisional, fluorescence
quenchers and the linearity indicates that static quenching is not mixed with the collisional
process. The population of the fluorescing sensitizer molecules inside the protein is
accessible to iodide ions, which penetrate from the external aqueous solution and cause
collisional dynamic quenching. The fact that the shape of the spectra did not change when
iodide was added also indicates that the quenching process is collisional and there is no
mechanism of static quenching.
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If the effect of a sensitizer’s depth in the BSA is to be deduced from the quenching of its
fluorescence, the intrinsic, depth-independent, fluorescence quenching efficiency of each
chromophore needs to be factored out. We achieve this by calculating the ratio between the
fluorescence quenching constants in BSA and in buffer. When these ratios are compared, the
influence of the fluorophore’s localization and exposure to external iodide ions is singled
out. We thus relate the quenching efficiencies that were observed in the non-isotropic
restricted phase of BSA, to the quenching in a homogeneous phase, buffer (Kq,BSA/Kq,buf).
By doing so, any intrinsic parameters that affect the quenching efficiency and are not related
to the changed location in the BSA, are delineated. As Table 1 demonstrates, the net
quenching efficiency of the BSA-bound sensitizers, which is due to the relative exposure of
the sensitizers to the external water phase, decreases as the chains lengthen.
These quenching results thus indicate that the sensitizers’ tetrapyrrole rings are located in
the protein binding site at different distances from the external water phase. As the length of
the side chains increases, the tetrapyrrole probably inserts and penetrates deeper into the
BSA cavity and is thus less exposed to external quenching. It is possible that the charged
carboxylates are anchored near the external, polar face of the globular protein.
Oxygenation of tryptophan photosensitized by bound sensitizers

$watermark-text
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We wished to corroborate the conclusion that was obtained from the iodide quenching
experiments, that within a group of similar sensitizers, elongation of the side chains places
the molecules at different positions in the albumin binding site. We thus measured the
efficiency at which tryptophan is being degraded by photosensitization when the sensitizers
were fully bound to the BSA. BSA has two tryptophan moieties, Trp135 and Trp212. The
second one is located near the binding site of porphyrins (Silvester et al. 1998; Tian et al.
2007). The proximity of a bound tetrapyrrole sensitizer to tryptophan should result in faster
photodegradation of the tryptophan by reaction with singlet oxygen, which is generated by
the sensitizer. The effect on a further removed tryptophan is expected to be small. While
attempting to carry out these experiments with the chlorins, we noticed that they underwent
self-photodestruction. The rate of this deterioration was not negligible compared to the rate
at which the tryptophan was photodamaged. The situation of a photosensitization reaction in
which the sensitizer itself is being photodamaged is quite common in photochemistry and
photobiology (Rotomskiene et al. 1988; Rotomskis et al. 1996). This is also manifested
strongly when photosensitizers in cells are observed under fluorescence microscopy. There
is indication that self-photobleaching of some porphyrins and chlorin e6 was enhanced when
these molecules were bound to human serum albumin (Bagdonas and Jasaitis 1997).
Evaluation of the sensitization of a target can still be obtained in such situation, with the aid
of the following kinetics that we have developed.
The intensity of light that is absorbed by the sensitizer, Iabs, in a sample whose optical
density at the illuminating wavelength is OD, is given by Eq. 4:
(4)

I0 is the intensity of incident light. If the initial optical density of the sensitizer, OD0, is
small, the following linearized series expansion can be taken:
(5)

The rate at which light is being absorbed by the sensitizer, whose concentration diminishes
exponentially with a rate of ks, due to self-destruction, is:
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(6)

where A contains the power of the laser. The destruction of a chemical target, T, by singlet
oxygen that is generated by photosensitization is given by:
(7)

ϕΔ is the singlet oxygen production yield. The solution of this differential equation is:

$watermark-text

(8)

If the sensitizer is stable, namely if ks approaches 0, the right term in Eq. 8 has both a
numerator and denominator that approach zero. According to l’Hospital’s rule:
(9)
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Under this condition, Eq. 8 evolves into the usual formula: T = T0e–(2.3·ϕΔ·OD·A)·t. Thus,
when the sensitizer itself is being destroyed, one should monitor the disappearance of the
chemical target, usually spectroscopically, and fit the data to Eq. 2Eq. 8 to extract ϕΔ. Figure
3 shows an example for fitting Eq. 8 to the degradation of BSA’s tryptophan by
photosensitization of the chlorin DB, which undergoes self-destruction under light. As can
be seen, the logarithm of tryptophan’s fluorescence intensity is not a linear function of time
but indeed exponential.
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Table 1 shows results of the sensitization of tryptophan by the different protoporphyrins,
hematoporphyrins and chlorins. Here, too, we wanted to separate the effect of the
sensitizer’s proximity to a near tryptophan from the intrinsic singlet oxygen production yield
by the sensitizer. We did this even though the differences in the net singlet oxygen
production efficiency between sensitizers within each group are very small, between 5 and
8%. Thus the relative values of the quantum yields of photo-degradation of tryptophan were
divided by the intrinsic singlet oxygen production yields of the sensitizers in a homogeneous
solution, without BSA. The values in the Table are normalized relative to the
photodestruction efficiency that is caused by PP3, HP5 and chlorin CD, respectively, which
were the most efficient destroyers of tryptophan among each group. These results indicate
that the efficiency at which tryptophan is being damaged depends on the nature of the
sensitizer, even after the small differences in the intrinsic singlet oxygen yields were
accounted for. One can infer from these results that for the hematoporphyrins and the
chlorins with phenyl substitution at the meso position, CX, elongation of the alkyl
carboxylate chains brings them to be located closer to the tryptophan in BSA, and the
normalized ϕD increases. In contrast, the three chlorins without substitution at the fifth
position, AX, are bound to BSA in such a way that places the analog with the short chain,
AB, closer to the nearest tryptophan than those with longer chains, AC and AD. A similar
trend is seen for the chlorins bearing a pentyl group, DB, DC and DD. For the
protoporphyrins and the chlorins with methyl substitution, the analog with a medium chain
length, PP3 and BC, respectively, are placed optimally relative to the tryptophan. As control
experiments we monitored tryptophan’s degradation in identical samples which were
bubbled with nitrogen, and contained 0.1 M sodium azide, a known physical quencher of
singlet oxygen. In such circumstances no decrease in BSA’s tryptophan fluorescence was
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observed upon illumination of the bound sensitizer. This proves that the damage that is
inflicted to tryptophan is indeed caused by photogenerated singlet oxygen.
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One could also consider the option that the differences between the tryptophan damage
kinetics arise not only from the proximity of the bound sensitizer to the tryptophan, but also
from variations in the singlet oxygen yield by the bound sensitizers due to the effect of their
location in the albumin. These intrinsic differences in the ϕΔ, which might arise from the
exact location of the sensitizer in the binding site could not be factored out, for the following
reason. We found that when the albumin-bound sensitizers are illuminated in the presence of
a water-solubilized chemical target of singlet oxygen, 9,10-anthracene dipropionic acid, no
significant destruction of this target could be observed. However, the same target was
destroyed very rapidly when both it and the sensitizers were in water, without BSA. We
conclude that singlet oxygen, which is generated by BSA-bound sensitizers, is scavenged
very efficiently by the tryptophan in BSA, which is close to it, as well as by other aromatic
acids and also by physical quenching by the protein in which it was generated. However,
even if differences in the location of the sensitizers in the albumin had an effect on singlet
oxygen’s yield, as mentioned above, it corroborates our claim that changes in the side chains
of the sensitizers cause their placement at different positions in the protein’s binding site. In
this context, we measured the fluorescence quantum yields (ϕF) of the chlorin sensitizers in
methanol as well as when bound to BSA, in comparison to rhodamine 101 as a fluorescent
standard, and found them to have very small variations. We thus think that the intrinsic yield
of singlet oxygen is also not varying and the differences in the photodestruction of
tryptophan are mainly a proximity effect.
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The trends of the data of fluorescence quenching by iodide and tryptophan photodamaging
cannot be mapped to each other, because they reflect non-correlated attributes. The first
depends on the accessibility of the bound chromophore to iodide ions that come from the
external aqueous medium while the latter reflects the proximity of the chromophore to
tryptophan within the BSA structure. The results do corroborate, however, the notion that
slight elongation of the side-chain affects the exact position of the sensitizers within BSA
and this is reflected in both measured parameters.

Conclusion

$watermark-text

We showed in this study that the strength and mode of binding of derivatized
hematoporphyrins, protoporphyrins and chlorins to BSA depends, for each of these groups,
on the chemical structures of the molecule. Most importantly, we show that the position of
the sensitizers within the protein binding site is affected by the length of the alkyl
carboxylate side chains, which were incrementally modified in all the studied groups of
molecules.
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BSA

Bovine serum albumin

DMA

9,10 Dimethylanthracene
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HP3

Hematoporphyrin IX

PBS

Phosphate-buffered saline

PDT

Photodynamic therapy

PP3

Protoporphyrin IX

DMSO

Dimethyl sulfoxide
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Fig. 1.

Chemical structures of HP, PP and chlorins and their modified analogs
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Fig. 2.

Stern–Volmer quenching plots for compound AD (150 nM) in PBS, pH = 7.20.
Fluorescence intensities were excited at 400 nm and measured at 645 nm
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Fig. 3.

Photodamaging of tryptophan (λex = 295 nm, λem = 340 nm) in BSA (20 mg/ml) by the
chlorin analog DB (3 μM). The logarithm of tryptophan’s fluorescence intensity is plotted
versus time and fitted to Eq. 8
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(1) Binding constants, Kb, of the sensitizers (0.1 μM) to BSA. (2) Numbers of binding sites in BSA, n. (3) I− fluorescence quenching constants of the
sensitizers when bound to BSA relative to the quenching when dissolved in buffer. [BSA] = 15 mg/ml for HP and PP and 10 mg/ml for chlorins. [PP] =
[HP] = 0.33 μM; [chlorins] = 0.15 μM. (4) Comparative efficiencies of singlet oxygentriggered photooxidation of BSA tryptophan, ϕ. The data in each
group are normalized to the sensitizer that had the highest relative efficiency
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